Home > Investing > Companies

Fornix

Price
 
Price € 0,65
Change -
Change % -
Open € 0,65
High € 0,65
Low € 0,65
Volume 4.101
Profile
 
Profile: Fornix BioSciences (merger of ARTU Biologicals and Dr. Fisher Farma) develops, manufactures and sells primarily patented pharmaceutical products. The activities are organized in three divisions, Fisher Farma, ARTU Biologicals Europe and Fornix Gene Technology. Fisher Farma is focused on trade in branded drugs, ARTU Biologicals Europe focuses in the production and sales activities in the market for immunotherapy products for allergic patients and Fornix Gene Technology focuses on biotechnology, including gene therapy.
Site: http://www.fornix.nl
Industry: Biotechnology
Description: Companies in the biotechnology industry are performing research and development activities for the purpose of discovering new drugs and diagnostics. The turnover of these companies comes from sales of these products or the sale of licenses of drugs and diagnostic to other companies.
2011
 

Profit and loss

Net profit (x 1 mln) € 0,18 Turnover (x 1 mln) € -0,20
Cashflow (x 1 mln) Tooltip € 10,58 Net cashflow (x 1 mln) Tooltip € -5,53

Balance

Private equity (x 1 mln) € 4,91 Foreign equity (x 1 mln) € 0,98
Current assets (x 1 mln) € 5,63 Current liabilities (x 1 mln) € 0,98
Working capital (x 1 mln) € 4,65 Balance total (x 1 mln) € 5,89

Share

Outstanding shares (x 1 mln) 7,732 Price year-end € 0,60
Dividend per share - Earnings per share € 0,02
Dividend yield - Cashflow per share € 1,37
Intrinsic value € 0,64 Net cashflow per share € -0,72
Price/intrinsic value 0,945

Key figures

Price/earnings 26,210 Price/cashflow 0,438
Price/net cashflow -0,839 Stockmarket value (x 1 mln) € 4,64
Solvability Tooltip 0,834 Solvability Tooltip 6,020
Return on private equity 3,60% Return on total equity 3,01%
Current ratio 5,763 Market value/PE 0,945
Market value/turnover -23,549 Enterprise value/turnover 0,070
History
 
Year 2011 2010 2009 2008 2007
Net profit (x 1 mln) € 0,18 € 13,62 € 11,05 € 10,27 € 13,98
Turnover (x 1 mln) € -0,20 € 22,48 € 37,76 € 39,83 € 84,73
Price year-end € 0,60 € 2,15 € 5,33 € 7,00 € 18,80
Year high € 2,74 € 7,55 € 6,28 € 20,25 € 24,35
Year low € 0,53 € 1,85 € 4,43 € 5,80 € 16,49
Outstanding shares (x 1 mln) 7,732 8,048 10,590 7,398 6,956
Price/earnings 26,210 1,270 5,107 5,045 9,354
Earnings per share € 0,02 € 1,69 € 1,04 € 1,39 € 2,01
Dividends - € 2,48 € 2,66 € 1,39 € 2,01
Dividend yield - 115,35% 49,92% 19,86% 10,69%
Pay out - 146,53% 254,95% 100,18% 100,00%
Private equity (x 1 mln) € 4,91 € 19,19 € 54,81 € 51,91 € 49,21
PE per share € 0,64 € 2,38 € 5,18 € 7,02 € 7,07
Balance total (x 1 mln) € 5,89 € 22,19 € 61,19 € 60,40 € 59,19
Stockmarket value (x 1 mln) € 4,64 € 17,30 € 56,42 € 51,79 € 130,77
Number of employees - 109 109 109 130